Telomir Pharmaceuticals, Inc.
What this means
- Exchange listing at riskOn Jan 12, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
- Net loss in 2025Net loss of $10.4M for the year (2024: −$16.5M).
What to do next
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Net income (loss) | −$10.4M | −$16.5M |
| Total assets | $7.3M | $1.3M |
| Total liabilities | $1.4M | $681K |
| Stockholders’ equity | $5.9M | $643K |
| Cash and equivalents | $7.3M | $1.3M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- Telomir Pharmaceuticals, Inc.
- CIK
- 0001971532
- Tickers
- TELO
- Kind of filer
- SEC-reporting company
Non-accelerated filer; Smaller reporting company; Emerging growth company - Status
- Filing with the SEC
- State of incorporation
- Florida
- Industry (SIC)
- 2834 · Pharmaceutical preparations
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 10-K for the period ended Dec 31, 2025
- Last quarterly report
- 10-Q for the quarter ended Sep 30, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Nov 6, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form 10-Q · filed Nov 6, 2026 · filing · edition of Nov 6, 2026
- Form 10-Q · filed Aug 13, 2026 · filing
- Form 8-K · items 5.02, 9.01 · filed Jun 8, 2026 · filing
- Form 10-Q · filed May 14, 2026 · filing
- Form 8-K · items 1.01, 2.01, 3.02, 9.01 · filed Apr 24, 2026 · filing
- Form 8-K · items 5.02, 5.03, 5.07, 9.01 · filed Mar 27, 2026 · filing
- Form 10-K · filed Mar 17, 2026 · filing
- Form 8-K · items 3.01 · filed Jan 12, 2026 · filing
- Form 8-K · items 5.02 · filed Dec 22, 2025 · filing
- Form 8-K · items 5.02, 9.01 · filed Nov 20, 2025 · filing
- Form 10-Q · filed Nov 10, 2025 · filing
- Form 10-Q · filed Aug 14, 2025 · filing
- Form 8-K · items 1.01, 3.02, 5.02, 9.01 · filed May 21, 2025 · filing
- Form 10-Q · filed May 14, 2025 · filing
- Form 10-K · filed Feb 4, 2025 · filing
- Form 8-K · items 4.01, 9.01 · filed Dec 20, 2024 · filing
- Form 8-K · items 5.02 · filed Nov 21, 2024 · filing
- Form 10-Q · filed Nov 12, 2024 · filing
- Form 10-Q · filed Aug 13, 2024 · filing
- Form 8-K · items 5.02, 9.01 · filed Jun 24, 2024 · filing
- Form 10-Q · filed May 13, 2024 · filing
- Form 8-K · items 5.02 · filed Apr 12, 2024 · filing
- Form 10-K · filed Mar 29, 2024 · filing
- Form 424B4 · filed Feb 12, 2024 · filing
- Form S-1 · filed Nov 14, 2023 · filing
- Form D · items 06b · filed Apr 3, 2023 · filing